Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
Colloids Surf B Biointerfaces. 2022 Sep;217:112651. doi: 10.1016/j.colsurfb.2022.112651. Epub 2022 Jun 20.
Gene therapy holds great promise for treatment of gene-associated diseases. However, safe and successful clinical application urgently requires further advancement of constructing efficient delivery systems. Herein, three amphiphilic peptide dendrimers (TTC-L-KRR/KKK/KHH), containing the natural amino acid residues (lysine K, arginine R, and histidine H) and AIE-based photosensitizer (tetraphenylethenethiophene modified cyanoacrylate, TTC) modified with alkyl chain (L), have been designed and prepared for improving therapeutic potency via the combination of gene therapy (GT) and photodynamic therapy (PDT). All three compounds possessed typical aggregation-induced emission (AIE) characteristics and ultralow critical micelle concentrations (CMCs). The liposomes consisting of amphiphilic peptide dendrimers and dioleoylphosphatidylethanolamine (DOPE) can effectively bind DNA into nanoparticles with appropriate sizes, regular morphology and good biocompatibility. Among them, liposomes TTC-L-KKK/DOPE exhibited the highest transfection efficiency up to 5.7-fold as compared with Lipo2000 in HeLa cells. Meanwhile, rapid endocytosis, successful endo/lysosomal escape, gene release and rapid nuclear delivery of DNA revealed the superiority of liposomes TTC-L-KKK/DOPE during gene delivery process. More importantly, efficient reactive oxygen species (ROS) generation by TTC-L-KKK/DOPE led to effective PDT, thus improving therapeutic potency via combining with p53 mediated-gene therapy. Our work brought novel insight and direction for the construction of bio-safe and bio-imaging liposome as the multifunctional nonviral gene vectors for the effective combined gene/photodynamic therapies.
基因治疗为基因相关性疾病的治疗带来了巨大的希望。然而,安全且成功的临床应用迫切需要进一步推进高效传递系统的构建。在此,设计并制备了三种包含天然氨基酸残基(赖氨酸 K、精氨酸 R 和组氨酸 H)和基于聚集诱导发光(AIE)的光敏剂(四苯乙烯噻吩修饰的氰基丙烯酸酯,TTC)的两亲性肽树状大分子(TTC-L-KRR/KKK/KHH),通过基因治疗(GT)和光动力治疗(PDT)的联合,提高治疗效果。所有三种化合物均具有典型的聚集诱导发光(AIE)特性和超低临界胶束浓度(CMC)。由两亲性肽树状大分子和二油酰基磷脂酰乙醇胺(DOPE)组成的脂质体可有效将 DNA 结合成具有适当尺寸、规则形态和良好生物相容性的纳米颗粒。其中,TTC-L-KKK/DOPE 脂质体在 HeLa 细胞中的转染效率最高,可达 Lipo2000 的 5.7 倍。同时,TTC-L-KKK/DOPE 脂质体具有快速的内吞作用、成功的内体/溶酶体逃逸、基因释放和 DNA 快速核转运,揭示了其在基因传递过程中的优越性。更重要的是,TTC-L-KKK/DOPE 产生的高效活性氧(ROS)导致有效的 PDT,从而通过与 p53 介导的基因治疗相结合提高治疗效果。我们的工作为构建生物安全和生物成像脂质体作为有效的多功能非病毒基因载体,用于有效的联合基因/光动力治疗,提供了新的见解和方向。